ISRG INTUITIVE SURGICAL INC
AI brief AI-written, not reviewed by a person
Latest figures show ISRG had cash and equivalents of 2.9781B as of 2026-09-30, up from 2.7604B as of 2026-06-30; stockholders’ equity was 15.9862B at 2026-09-30, down from 18.1684B at 2026-06-30; diluted EPS (year) for 12 months to 2025-12-31 was 7.87 USD, vs 6.42 USD for 2024-12-31. Quarterly metrics indicate continuing revenue strength with 3Q26 revenue of 3.0487B and 3Q26 operating income of 0.5926B, versus prior quarters in 2025 and 2024 as reported.
- Cash and equivalents at 2026-09-30: 2,978,100,000 USD; 2026-06-30: 2,760,400,000 USD; 2026-03-31: 2,006,500,000 USD; 2025-12-31: 3,368,000,000 USD; 2025-09-30: 2,806,600,000 USD. [1]
- Diluted EPS (year): 12 months to 2025-12-31: 7.87 USD; 12 months to 2024-12-31: 6.42 USD. [1]
- Diluted EPS (quarter): 3 months to 2026-09-30: 1.49 USD; 3 months to 2026-06-30: 2.29 USD; 3 months to 2026-03-31: 2.28 USD; 3 months to 2025-09-30: 1.95 USD; 3 months to 2025-06-30: 1.81 USD. [1]
- Stockholders’ equity: 15,986,200,000 USD at 2026-09-30; 18,168,400,000 USD at 2026-06-30; 17,474,500,000 USD at 2026-03-31; 17,824,000,000 USD at 2025-12-31; 16,929,700,000 USD at 2025-09-30. [1]
- Net income (year): 2,856,000,000 USD for 12 months to 2025-12-31; 2,322,600,000 USD for 12 months to 2024-12-31. [1]
- Net income (quarter): 3 months to 2026-09-30: 522,800,000 USD; 3 months to 2026-06-30: 818,100,000 USD; 3 months to 2026-03-31: 821,500,000 USD; 3 months to 2025-09-30: 704,400,000 USD; 3 months to 2025-06-30: 658,400,000 USD. [1]
- Operating cash flow (year): 3,030,500,000 USD for 12 months to 2025-12-31; 2,415,000,000 USD for 12 months to 2024-12-31. [1]
- Operating cash flow (quarter): 3 months to 2026-03-31: 911,900,000 USD; 3 months to 2025-03-31: 581,600,000 USD. [1]
- Operating income (year): 2,945,500,000 USD for 12 months to 2025-12-31; 2,348,900,000 USD for 12 months to 2024-12-31. [1]
- Operating income (quarter): 3 months to 2026-09-30: 592,600,000 USD; 3 months to 2026-06-30: 971,900,000 USD; 3 months to 2026-03-31: 855,300,000 USD; 3 months to 2025-09-30: 759,700,000 USD; 3 months to 2025-06-30: 743,400,000 USD. [1]
- Revenue (year): 12 months to 2025-12-31: 10,064,700,000 USD; 12 months to 2024-12-31: 8,352,100,000 USD. [1]
- Revenue (quarter): 3 months to 2026-09-30: 3,048,700,000 USD; 3 months to 2026-06-30: 2,892,300,000 USD; 3 months to 2026-03-31: 2,770,800,000 USD; 3 months to 2025-09-30: 2,505,100,000 USD; 3 months to 2025-06-30: 2,440,000,000 USD. [1]
- Shares outstanding: 346,643,718 shares at 2026-10-15; 353,278,038 shares at 2026-07-16; 354,162,842 shares at 2026-04-15; 355,130,237 shares at 2026-01-28; 354,496,073 shares at 2025-10-16. [1]
- Total assets: 19,349,100,000 USD at 2026-09-30; 20,876,600,000 USD at 2026-06-30; 20,111,000,000 USD at 2026-03-31; 20,458,700,000 USD at 2025-12-31; 19,351,800,000 USD at 2025-09-30. [1]
- Total liabilities: 3,231,300,000 USD at 2026-09-30; 2,578,900,000 USD at 2026-06-30; 2,513,800,000 USD at 2026-03-31; 2,517,000,000 USD at 2025-12-31; 2,309,700,000 USD at 2025-09-30. [1]
- Filings: 10-Q filed 2026-10-21 (accession 0001035267-26-000071); 8-K filed 2026-10-20 (accession 0001035267-26-000067). [1][2]
Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).
Observations
| Metric | Value | Observed | Source | Retrieved | Freshness |
|---|---|---|---|---|---|
| Revenue (quarter) (3 months to 2026-09-30) | 3,048,700,000 USD | sec-companyfacts | current | ||
| Revenue (year) (12 months to 2025-12-31) | 10,064,700,000 USD | sec-companyfacts | current | ||
| Net income (quarter) (3 months to 2026-09-30) | 522,800,000 USD | sec-companyfacts | current | ||
| Net income (year) (12 months to 2025-12-31) | 2,856,000,000 USD | sec-companyfacts | current | ||
| Operating income (quarter) (3 months to 2026-09-30) | 592,600,000 USD | sec-companyfacts | current | ||
| Operating income (year) (12 months to 2025-12-31) | 2,945,500,000 USD | sec-companyfacts | current | ||
| Diluted EPS (quarter) (3 months to 2026-09-30) | 1.49 USD/shares | sec-companyfacts | current | ||
| Diluted EPS (year) (12 months to 2025-12-31) | 7.87 USD/shares | sec-companyfacts | current | ||
| Operating cash flow (quarter) (3 months to 2026-03-31) | 911,900,000 USD | sec-companyfacts | current | ||
| Operating cash flow (year) (12 months to 2025-12-31) | 3,030,500,000 USD | sec-companyfacts | current | ||
| Total assets (at 2026-09-30) | 19,349,100,000 USD | sec-companyfacts | current | ||
| Total liabilities (at 2026-09-30) | 3,231,300,000 USD | sec-companyfacts | current | ||
| Stockholders' equity (at 2026-09-30) | 15,986,200,000 USD | sec-companyfacts | current | ||
| Cash and equivalents (at 2026-09-30) | 2,978,100,000 USD | sec-companyfacts | current | ||
| Shares outstanding (at 2026-10-15) | 346,643,718 shares | sec-companyfacts | current |
Context
No reviewed context has been published for ISRG. The observations and documents below are shown as their sources stated them.
Documents
Source freshness
| Source | Freshness | Last successful fetch | Stale after | Sources reports |
|---|---|---|---|---|
| SEC EDGAR: company financial facts (XBRL) sec-companyfacts | current | 10080 min | ok | |
| SEC EDGAR: latest XBRL filings sec-xbrl-filings | current | 45 min | healthy |
Watch this instrument
Sign in to add ISRG to a private watchlist or to get an alert when a new document or observation arrives.
Machine-readable: ISRG.json (the same data with every timestamp and source).
Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.